- 全部删除
- 您的购物车当前为空
Tivumecirnon (FLX475) 是一种选择性和具有口服活性的CCR4拮抗剂,抑制调节性T细胞(Treg)向肿瘤微环境的浸润和迁移,具有抗肿瘤活性。
为众多的药物研发团队赋能,
让新药发现更简单!
Tivumecirnon (FLX475) 是一种选择性和具有口服活性的CCR4拮抗剂,抑制调节性T细胞(Treg)向肿瘤微环境的浸润和迁移,具有抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,730 | In stock | |
5 mg | ¥ 4,290 | In stock | |
10 mg | ¥ 5,970 | In stock | |
25 mg | ¥ 8,870 | In stock | |
50 mg | ¥ 12,200 | In stock | |
100 mg | ¥ 16,300 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 5,160 | In stock |
Tivumecirnon 相关产品
产品描述 | Tivumecirnon (FLX475) is a selective and orally active CCR4 antagonist that inhibits the infiltration and migration of regulatory T cells (Tregs) into the tumour microenvironment, exhibiting antitumour activity. |
别名 | 替沃西孟, FLX475, FLX 475 |
分子量 | 543.41 |
分子式 | C24H27Cl2F3N6O |
CAS No. | 2174938-78-2 |
Smiles | [C@H](C)(N1C=2C(C(C(F)(F)F)=N1)=NC=C(N2)N3CC(C3)[C@@H]4CN(CCO)CCC4)C5=C(Cl)C=C(Cl)C=C5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (147.22 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容